NeoVaxSyn, Inc.
NeoVaxSyn Inc., founded by Dr. Michael Cho, is developing immunogens and optimizing vaccine technologies that can enable the body’s immune system to better target critical epitopes on viral surface antigens.
NeoVaxSyn Inc., founded by Dr. Michael Cho, is developing immunogens and optimizing vaccine technologies that can enable the body’s immune system to better target critical epitopes on viral surface antigens.